The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis.
about
Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertasesComplement receptor is an inhibitor of the complement cascadeComplement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosusInhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol)Identification of a partial cDNA clone for the human receptor for complement fragments C3b/C4bThe immune-adherence phenomenon; a hypothetical role of erythrocytes in defence against bacteria and virusesIndividuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiologyEnhanced neutralization potency of botulinum neurotoxin antibodies using a red blood cell-targeting fusion proteinInfections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyClearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherenceUse of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatmentIn vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzeesComplement-independent binding of microorganisms to primate erythrocytes in vitro by cross-linked monoclonal antibodies via complement receptor 1Absence of erythrocyte-associated HIV-1 in vivoComplement system in synovial fluids from patients with rheumatoid arthritis.Attachment of virulent Treponema pallidum to human mononuclear phagocytesMicrocapsule agglutination test for Treponema pallidum antibodies. A new serodiagnostic test for syphilis.Studies on the fluorescent treponemal antibody (FTA) test.Quantitative evolutionary design of glucose 6-phosphate dehydrogenase expression in human erythrocytes.Genetic regulation of a structural polymorphism of human C3b receptor.Rate of clearance of virulent Treponema pallidum (Nichols) from the blood stream of normal, Mycobacterium bovis BCG-treated, and immune syphilitic rabbits.SERUM FACTORS OF ACQUIRED HEMOLYTIC ANEMIA IN LEUKEMIA AND LYMPHOMAReactivity of red cell eluates and serums in patients with acquired hemolytic anemia and chronic lymphocytic leukemia.Meningococcal disease and the complement system.Passive sensitization of lymphocytes and macrophages by antigen-antibody complexes.Presence of IgG anti-gp160/120 antibodies confers higher HIV capture capacity to erythrocytes from HIV-positive individuals.Complete absence of the third component of complement in man.Presence of p24-antigen associated to erythrocyte in HIV-positive individuals even in patients with undetectable plasma viral loadLigation of complement receptor 1 increases erythrocyte membrane deformabilityAltered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.Overexpression of complement receptor type I (CR1, CD35) on erythrocytes in patients with hemoplasma infection.The atherogenic bacterium Porphyromonas gingivalis evades circulating phagocytes by adhering to erythrocytes.Reiter protein complement fixation test; a preliminary comparison of the TPI test with the complement fixation test employing a soluble protein antigen derived from the Reiter strain.Serologic diagnosis of syphilis; the use of Treponema pallidum immobilization and immune adherence tests.Immune adherence revisited: novel players in an old game.Viable bacteria associated with red blood cells and plasma in freshly drawn blood donationsNeisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human bloodHomozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis.C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
P2860
Q22010707-39774EAC-55F6-4F39-AAE3-395BDB406799Q24302183-7D6A51B3-57E9-440E-8A2D-7BADB04B251CQ24302256-76248A95-95B8-4EE5-8088-A9230C49EAEFQ24527312-1D93A032-D52C-4725-9FB6-77A1D8E276FBQ24608807-C88B9290-B1B8-4C53-9A3F-7F461C732411Q24675680-99D91E36-5AB5-44E9-9E75-DE9F1F9463BFQ26775404-66269AAF-6F43-4888-9788-FC14797FC132Q28742292-3610CD7B-7934-4B19-9E3B-77B84C51EDBEQ28972389-EFE884C2-A08F-4C9B-A9B7-9D4DFDEB442EQ30306247-9E95A9CC-628E-4C12-B38B-4C685CA71D52Q30433651-748A2FC9-3D59-4889-B79C-C16DDA75B770Q30445571-E1F4BD1C-2291-41C0-8C7C-E9358107DACBQ30449835-9A604881-2EC4-412B-B47B-7317608064DAQ30452831-AE2FD0F3-348B-4B56-B81C-AF605C252FF9Q33290541-E2FC538D-FA48-475E-B7CB-816B4F2946F8Q33580015-D3CADD60-4548-4AD4-9ED6-92D88BB2E6E2Q33655939-F0AC165C-EB22-496B-B273-783AB7C5586CQ33659217-A427BD44-8116-40B5-97C7-30705F72073DQ33664435-6C532878-851E-4BDF-B17A-3AB33FDF5130Q33717873-260C710C-A64D-42ED-A2F2-9128A9E6A10BQ33822131-069DEEA3-4698-4B5B-8184-23F0E03E30DDQ33898603-ADB0129B-9E46-4808-86C4-F838246C0C0DQ34007306-E6D82E72-76FA-4A56-9CC3-D3D4CA3A90B8Q34017613-C3F1D140-CDB7-4BA8-A893-B3EAE2E5E63EQ34376170-A90EB9C9-E4D9-4718-B377-17E448145FEFQ34420690-CD4F0949-39B1-49CB-822B-1609BAE41F86Q34438445-9A6E8141-26B7-4381-B4FD-BB91AAE177C7Q34481903-972674F0-35EB-46CB-86F3-236532366668Q34498821-92C5279B-319D-4B5B-8747-7983297CA647Q34541629-B737AC8C-476D-44CC-9E7B-F556C8D3280FQ34542184-C9DD9B1F-8918-4E8F-8DA6-90F09016C90CQ34621711-FC7D71B5-FA1D-4060-8D03-DA996F578F80Q34740007-D5B15C07-79B9-4437-AE77-AA26BD6FECA3Q34801944-C4D7DEA6-5712-44B8-B4C3-8E7B8B0A9FF2Q34931875-A9A884A9-07AF-4D70-BB36-5255BD9BD66DQ35128780-93DF0927-4EBE-4E48-8D4A-07CC456B9F20Q35159128-C64F39A9-8E1D-4384-AF7E-7736E80E4C54Q35186384-B72D832E-51FC-4D37-AAB3-F9E47ADA47A4Q35196708-CF555009-DDDF-435C-A2D1-D92EBDFA1F17Q35201919-88E7A336-283F-467E-978E-056A5D134C05
P2860
The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis.
description
1953 nî lūn-bûn
@nan
1953 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1953 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1953年の論文
@ja
1953年論文
@yue
1953年論文
@zh-hant
1953年論文
@zh-hk
1953年論文
@zh-mo
1953年論文
@zh-tw
1953年论文
@wuu
name
The immune-adherence phenomeno ...... ding to enhanced phagocytosis.
@ast
The immune-adherence phenomeno ...... ding to enhanced phagocytosis.
@en
The immune-adherence phenomeno ...... ding to enhanced phagocytosis.
@nl
type
label
The immune-adherence phenomeno ...... ding to enhanced phagocytosis.
@ast
The immune-adherence phenomeno ...... ding to enhanced phagocytosis.
@en
The immune-adherence phenomeno ...... ding to enhanced phagocytosis.
@nl
prefLabel
The immune-adherence phenomeno ...... ding to enhanced phagocytosis.
@ast
The immune-adherence phenomeno ...... ding to enhanced phagocytosis.
@en
The immune-adherence phenomeno ...... ding to enhanced phagocytosis.
@nl
P1433
P1476
The immune-adherence phenomeno ...... ding to enhanced phagocytosis.
@en
P2093
NELSON RA Jr
P304
P356
10.1126/SCIENCE.118.3077.733
P407
P577
1953-12-01T00:00:00Z